טוען...
An expert consensus to standardize definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease
BACKGROUND: Fibrotic stricture is a common complication of Crohn’s disease (CD) affecting approximately half of all patients. No specific anti-fibrotic therapies are available; however, several therapies are currently under evaluation. Drug development for the indication of stricturing CD is hampere...
שמור ב:
| הוצא לאור ב: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043370/ https://ncbi.nlm.nih.gov/pubmed/29920726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14853 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|